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ABSTRACT

TxtE is a protein related to cytochrome P450 enzymes, which catalyze a number of reactions that
typically involve oxygen and not nitrogen. It has been discovered that TxtE can nitrate tryptophan
through an unusual reaction in which it uses nitric oxide (NO) as a nitrogen donor to install the
nitro group despite NO typically being considered toxic to bacteria. This project will determine if
all cytochromes P450 can catalyze nitration as long as they are given NO. This will have an impact
on understanding drug delivery and metabolism for which nitration is important.
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INTRODUCTION
Cytochromes P450 (CYPs) catalyze the biodegradation of drugs and foreign substances called
xenobiotics. Many drugs function as CYP inhibitors (to increase the potency of a drug) or, CYP
inducers (to increase metabolism of a drug by influencing a metabolic pathway), or CYP substrates
(to eliminate drugs and other metabolites). Fifty-seven CYPs have been characterized for their
drug metabolism activities in humans. Much of this metabolism occurs in the liver where CYP3A4
is the predominant enzyme.1 There is evidence that during the liver disease cirrhosis, drug
metabolism is inhibited due to changes in the liver decreasing the number of hepatocytes and drug
metabolizing enzymes like CYPs. Interestingly, there is also a strong correlation between
reduction in CYP activity and increased severity of cirrhosis, specifically in the content and
activity of CYP1A, 2C19 and 3A, implicating the importance of CYP mediation in preventing the
onset and progression of diseases.2,3
Some well-known CYP inhibitors include antibiotics (clarithromycin, erythromycin), calcium
channel blockers (diltiazem, verapamil), antidepressants (fluvoxamine, fluoxetine, and sertraline,
also known as Zoloft), and even anti-HIV agents (delavirdine, ritonavir).4 CYP inducers include
rifampin (used to treat tuberculosis), carbamazepine, and phenytoin (anticonvulsants used to treat
seizures and epilepsy). Similarly, CYP substrates include caffeine and ibuprofen, in which CYPs
eliminate the inactive metabolites via oxidative metabolism.5,6
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Significance
The potential of CYPs being able to perform nitration chemistry when put under the same
conditions as TxtE (the addition of nitric oxide and removal of an electron) has applications in the
creation of disease-fighting pharmaceutics. Many drugs contain nitro groups, which assist in the
synthesis of complex drug compounds. Typical nitration methods used industrially involve nitric
acid (Scheme 6) to add the nitro group but it is severely limited as it is non-selective and creates
large amounts of dangerous acidic waste. The potential of CYPs to function as a nitration
biocatalyst presents a highly selective and non-toxic alternative.7

Cytochrome P450 Typical Behavior: Hydroxylation
CYPs are heme-dependent enzymes that usually function as monooxygenases. When given a
substrate and dioxygen (O2), one of the oxygen atoms is incorporated into the substrate while the
other is reduced to water.8 The most common example of mono-oxygenase activity is
hydroxylation in which an R-OH group is added to substrates (Figure 1). The reaction requires the
input of two electrons.

Figure 1. Balanced equation for the hydroxylation of substrate by CYPs.

2

Decades of mechanistic research have provided detailed insight into the reaction pathway of
substrate hydroxylation by CYP.9 The accumulated findings are summarized in Figure 2. A
substrate, depicted as RH in Figure 2, binds to the CYP, followed by the donation of a single
electron to Fe3+ from an electron source, reducing it to Fe2+. A molecule of O2 then quickly binds
Fe2+ and forms the ferric-superoxo (Fe3+-O2-) complex. A second electron then reduces the heme
bound O2 to form a ferric-peroxo complex (Fe3+-O22-). Two protonation events result in cleavage
of the O–O bond, resulting in the formation of water and a highly oxidizing intermediate called
Compound I. The reactivity of Compound I enables transfer of a hydrogen atom from the substrate
to form Compound II and a substrate radical. Radical rebound to the substrate radical results in
formation of the hydroxylated product.
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Figure 2. A simplified general catalytic cycle of Cytochrome P450 depicting the hydroxylation of a substrate RH.10
Step 1 shows substrate-binding while steps 2 and 4 demonstrate the reduction steps of the cycle. Step 3 is the
binding of O2, which is then cleaved in step 5 resulting in the release of a water molecule. The remaining oxygen
atom is then transferred to the substrate in step 6 resulting in the release of the hydroxylated substrate in step 7.
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TxtE Can Nitrate L-Tryptophan
It has been discovered that a cytochrome P450 homolog, TxtE, can catalyze nitration in the first
step of the biosynthesis of thaxtomin A, a phytotoxin produced by Streptomyces species.11 This
biosynthesis was elucidated via examination of potatoes infected with scab disease, which causes
lesions, or scabs, on the potato tubers. Pathogens reside and reproduce in these lesions and are
caused by Streptomyces species. Evidence shows that thaxtomin A biosynthesis allows these
lesions to form and be plant pathogenic.
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More specifically, this molecule inhibits cellulose

biosynthesis in plants It involves TxtA and TxtB, which encode non-ribosomal peptide synthases
that produce its N-methylated cyclic dipeptide backbone, and TxtC, a P450 monooxygenase that
hydroxylates the backbone.11 The nitro (R-NO2) group present on thaxtomin is required for its
phytotoxicity and originates from the precursor L-4-nitrotryptophan, which is incorporated into the
N,N’-dimethyldiketopiperazine core of thaxtomin A by TxtA and TxtB. Typically, oxidation of
an amino group (-NH2) is the source of nitro groups in natural products, but in thaxtomin A, the
4-nitrotryptophan precursor is generated by the enzyme TxtE, which catalyzes the regioselective
nitration, or addition of a nitro group, onto L-tryptophan. This enzyme obtains electrons from
NADPH via electron transfer proteins and both O2 and NO are used as co-substrates (Figure 3).
TxtD, a bacterial nitric oxide synthase, oxidizes arginine present in the thaxtomin, resulting in the
formation of citrulline and nitric oxide.13 This is unusual, as NO is typically toxic to bacteria.

5

Figure 3. Canonical nitration of L-tryptophan by TxtE in the biosynthesis of thaxtomin A.
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HYPOTHESIS
We predict that if we introduce a canonical CYP to the reaction conditions encountered by TxtE
during nitration of L-tryptophan—i.e., addition of NO limiting the reducing equivalents to a single
electron--that the any canonical CYP enzyme will catalyze nitration of its substrate. In the case of
CYP101A1, the native substrate is camphor. Therefore, we propose that under nitration conditions,
the proposed reaction will form nitrated camphor (Figure 4).

Figure 4. Typical hydroxylation of camphor performed by CYPs (top). The bottom Figure depicts the predicted
nitration of camphor by CYPs, whose regiospecificity is unknown (bottom).
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EXPERIMENTAL
The cytochrome P450 that was used to test for substrate nitration is CYP101A1. It originates from
Pseudomonas putida and is one of the most well characterized CYPs. To express and purify
CYP101A1, a previously reported protocol was followed.14 E. coli cells containing pP450cam, a
plasmid with a pET-28b(+) vector backbone with a 6x His-tagged CYP101A1 gene inserted into
it,were grown in a starter culture of TB media containing ampicillin and then lysed by lysozyme.
Unwanted protein was separated from the protein of interest, CYP101A1, via heat denaturation
(sitting in a water bath of 75℃ for about 15 minutes) then removed via centrifugation. CYP101A1
was then be salted out of the remaining supernatant via ammonium sulfate precipitation. The
remaining ammonium sulfate pellet was resuspended in 20 mM potassium phosphate buffer and
isolated on a cobalt IMAC column. Gel filtration was performed to isolate the protein by size
followed by purity analysis using SDS-PAGE. Pure fractions were pooled and concentrated to
ensure proper expression and purification of the protein. Samples of CYP101A1, (substrate), 50
mm Tris buffer, and PROLI-NONOate (source of NO) were prepared under anaerobic conditions
in a glove box and then exposed to O2 via removal from the glove box to perform nitration. Liquid
chromatography–mass spectrometry (LC-MS) were used to identify nitrated camphor via its molar
mass after the removal of an H and the addition of a NO2 group (~198 g/mol).
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Results
The CYP101A1 protein was purified using literature protocols. SDS-PAGE analysis (Figure 5)
shows that protein samples exhibit one major band indicative of the obtainment of pure protein. In
addition, the band migrates at the expected size of CYP101A1 (~47 kDa). Fractions containing the
protein were pooled and determined to have a concentration of 1.02 mM as determined by BCA
assay.

Figure 5. SDS-PAGE of CYP101A1. Fractions of CYP101A1 collected from the cobalt IMAC column were loaded
into lanes of 8% stacking and 12% resolving polyacrylamide gel.

9

Next, the protein was used to test the hypothesis that CYP101A1 could perform nitration of
camphor. Samples mixtures were prepared containing 50 mM Tris buffer, 400 mM camphor, 6
µM sodium dithionite, 100 mM CYP101A1, and 3.5 mM PROLI NONOate. Oxygen was added
via removal of the sample mixture from the anaerobic glovebox. LC-MS analysis showed no peaks
of m/z 198 in the extracted ion chromatogram (Figure 6), whose presence would indicate the
formation of nitrocamphor. This result indicates that CYP101A1 is not capable of nitrating
camphor to nitrocamphor.

Figure 6. Liquid chromatography coupled to mass spectrometry extracted ion chromatogram of samples with
camphor, CYP101A1, NO, and O2. Controls without each of the following components were measured: 3.5 mM
PROLI NONOate (purple), 100 mM CYP101A1 (green), and 50 µM sodium dithionite (blue). Reaction mixture of
PROLI NONOate, CYP101A1, sodium dithionite, 50 mm Tris buffer, and oxygen (added via removal of samples
from anaerobic glove box).
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Discussion
Despite being structural homologs, TxtE and CYP101A1 are not both capable of nitration.
CYP101A1, which can hydroxylate camphor, was unable to nitrate camphor when put under the
same experimental conditions as TxtE (Figure 4). The collected data disproves the hypothesis
introducing a canonical CYP to the same nitration conditions as TxtE (adding NO and limiting the
reducing equivalents to a single electron) would result in nitration of camphor.
The results imply that there are structural differences between TxtE and CYP101A1 that commits
P450s to hydroxylation and TxtE to nitration. Further investigation of the active site (Figure 7)
shows that the inner spheres of the enzymes’ active sites are similar, both containing a cysteine
and heme group. By contrast, there are clear differences in the outer coordination sphere of the
active site. TxtE’s outer sphere contains proline residues in place of a critical acid-alcohol pair
(D251 and T252 in CYP101A1) that are essential for camphor hydroxylation. Future experiments
should focus on if the H-bond network mediated by the acid-alcohol pair prevents nitration or how
the homologous proline residues in TxtE allow for nitration. Alternatively, there is an inherent
difference in the structure of the substrates. The TxtE substrate, tryptophan is aromatic while
camphor, the CYP101A1 substrate, is not. The inability of CYP101A1 could result from these
different substrates. Nitration in CYP101A1 or similar monooxygenase enzymes could be tested
with aromatic substrates to test if the reaction is substrate dependent.
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Figure 7.15 Comparison of the the active site of CYP101A1 and camphor and TxtE bound to Tryptophan. D251 is
analogous to P249, N255 is analogous to P252, and T252 is analogous to T250.

Conclusion
The canonical CYP, CYP101A1, was unable to nitrate camphor when put under the same
experimental conditions as TxtE. These findings could lead to further experiments to gain insight
into how the structures of TxtE and CYP101A1 influence their function. Examination of the active
sites of TxtE and CYP101A1 (Figure 7) shows similarity in the inner sphere of the active sites, but
differences in the outer spheres. The outer sphere of the active site of TxtE, for instance, contains
proline residues in place of a critical acid-alcohol pair (D251 and T252 in CYP101A1) that are
essential for camphor hydroxylation. Future work could use mutagenesis to change the branched
amino acid residues of CYP101A1 to cyclic amino acid residues similar to the proline residues in
TxtE. Similarly, catalysis of nitration could be tested with other substrates to determine if the
reaction is substrate dependent. TxtE nitrates tryptophan, a cyclic compound, but CYP101A1
favors camphor, which has a bridged structure, as a substrate. A cytochrome P450 that binds a
cyclic compound like tryptophan could be used to test for catalysis of nitration.
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